---
pmid: '27133716'
title: A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar
  ataxia 3 polyglutamine aggregation in a J-domain independent manner.
authors:
- Ito N
- Kamiguchi K
- Nakanishi K
- Sokolovskya A
- Hirohashi Y
- Tamura Y
- Murai A
- Yamamoto E
- Kanaseki T
- Tsukahara T
- Kochin V
- Chiba S
- Shimohama S
- Sato N
- Torigoe T
journal: Biochem Biophys Res Commun
year: '2016'
full_text_available: false
doi: 10.1016/j.bbrc.2016.03.152
---

# A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent manner.
**Authors:** Ito N, Kamiguchi K, Nakanishi K, Sokolovskya A, Hirohashi Y, Tamura Y, Murai A, Yamamoto E, Kanaseki T, Tsukahara T, Kochin V, Chiba S, Shimohama S, Sato N, Torigoe T
**Journal:** Biochem Biophys Res Commun (2016)
**DOI:** [10.1016/j.bbrc.2016.03.152](https://doi.org/10.1016/j.bbrc.2016.03.152)

## Abstract

1. Biochem Biophys Res Commun. 2016 Jun 10;474(4):626-633. doi: 
10.1016/j.bbrc.2016.03.152. Epub 2016 Apr 28.

A novel nuclear DnaJ protein, DNAJC8, can suppress the formation of 
spinocerebellar ataxia 3 polyglutamine aggregation in a J-domain independent 
manner.

Ito N(1), Kamiguchi K(2), Nakanishi K(2), Sokolovskya A(2), Hirohashi Y(2), 
Tamura Y(2), Murai A(2), Yamamoto E(2), Kanaseki T(2), Tsukahara T(2), Kochin 
V(2), Chiba S(3), Shimohama S(4), Sato N(2), Torigoe T(5).

Author information:
(1)Department of Pathology, Sapporo Medical University School of Medicine, 
South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan; Department of Neurology, 
Sapporo Medical University School of Medicine, South-1, West-17, Chuo-ku, 
Sapporo 060-8556, Japan.
(2)Department of Pathology, Sapporo Medical University School of Medicine, 
South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan.
(3)Department of Neurology, Clinical Brain Research Laboratory, Toyokura 
Memorial Hall, Sapporo Yamano-ue Hospital, Japan.
(4)Department of Neurology, Sapporo Medical University School of Medicine, 
South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan.
(5)Department of Pathology, Sapporo Medical University School of Medicine, 
South-1, West-17, Chuo-ku, Sapporo 060-8556, Japan. Electronic address: 
torigoe@sapmed.ac.jp.

Polyglutamine (polyQ) diseases comprise neurodegenerative disorders caused by 
expression of expanded polyQ-containing proteins. The cytotoxicity of the 
expanded polyQ-containing proteins is closely associated with aggregate 
formation. In this study, we report that a novel J-protein, DNAJ (HSP40) 
Homolog, Subfamily C, Member 8 (DNAJC8), suppresses the aggregation of 
polyQ-containing protein in a cellular model of spinocerebellar ataxia type 3 
(SCA3), which is also known as Machado-Joseph disease. Overexpression of DNAJC8 
in SH-SY5Y neuroblastoma cells significantly reduced the polyQ aggregation and 
apoptosis, and DNAJC8 was co-localized with the polyQ aggregation in the cell 
nucleus. Deletion mutants of DNAJC8 revealed that the C-terminal domain of 
DNAJC8 was essential for the suppression of polyQ aggregation, whereas the 
J-domain was dispensable. Furthermore, 22-mer oligopeptide derived from 
C-termilal domain could suppress the polyQ aggregation. These results indicate 
that DNAJC8 can suppress the polyQ aggregation via a distinct mechanism 
independent of HSP70-based chaperone machinery and have a unique protective role 
against the aggregation of expanded polyQ-containing proteins such as pathogenic 
ataxin-3 proteins.

Copyright Â© 2016 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.bbrc.2016.03.152
PMID: 27133716 [Indexed for MEDLINE]
